THE CLINICAL CASES OF KERATOCONJUNCTIVITIS ENCOUNTERED IN THE PEDIATRIC PATIENTS PRESENTING WITH ATOPIC DERMATITIS


Cite item

Full Text

Abstract

The eye damage in the children presenting with atopic dermatitis is known to occur in 20-40% of the cases. The nonspecific nature of the ophthalmological symptoms of this pathology markedly complicates differential diagnostics and the choice of the pathogenetically-based therapeutic modalities. This article describes the clinical cases that demonstrate the seriousness of this problem and illustrate the necessity of the comprehensive interdisciplinary approach to its solution. It is concluded that the use of the “Restasis” pharmaceutical for the treatment of dry eye syndrome associated with atopic dermatitis in the young patients is justified as contributing to a stable remission of the disorder and producing no undesirable side effects.

About the authors

I. E Panova

The S.N. Fyodorov Eye Microsurgery Federal State Institution, the Saint-Petersburg branch

Saint-Petersburg, 192283, Russian Federation

Lyudmila Anatol’evna Patlasova

Federal state budgetary healthcare facility “Chelyabinsk Regional Children’s Clinical Hospital”

Email: Lus.e@mail.ru
ophthalmologist for Department of Ophthalmology, Federal state budgetary healthcare facility “Chelyabinsk Regional Children’s Clinical Hospital”, Chelyabinsk, 454092, Russian Federation 454092, Chelyabinsk, Russian Federation

L. A Chervonyak

Federal state budgetary healthcare facility “Chelyabinsk Regional Children’s Clinical Hospital”

454092, Chelyabinsk, Russian Federation

E. P Tagieva

Federal state budgetary healthcare facility “Chelyabinsk Regional Children’s Clinical Hospital”

454092, Chelyabinsk, Russian Federation

References

  1. Федеральные клинические рекомендации по оказанию медицинской помощи детям с атопическим дерматитом / Под ред. акад. РАН А.А. Баранова, чл.-корр. РАН Л.С. Намазовой-Барановой [Электронный ресурс] // URL: http://www.pediatr-russia.ru/sites/default/files/file/kr_ad.pdf (дата обращения 27.07.2016).
  2. Watson W., Kapur S. Atopic dermatitis. Allergy, Asthma Clin. Immunol. 2011; 7 (Suppl. 1): S4. [Электронный ресурс] // URL: http://aacijournal.biomedcentral.com/articles/10.1186/1710-1492-7-S1-S4. (дата обращения 27.07.2016).
  3. Самцов А.В., Соколовский Е.В., Аравийская Е.А. Рекомендации по лечению топического дерматита (атопической экземы) Американской академии дерматологии, Европейской академии дерматовенерологии и Российского общества дерматовенерологов и косметологов. Вестн. дерматол. 2015; (6): 11-6.
  4. Майчук Ю.Ф. Конъюнктивиты. Современная лекарственная терапия: Краткое пособие для врачей. 2-е изд. М.; 2014.
  5. Van der Merwe R., Gianella-Borradori А. Industry Perspective on the Clinical Development of Systemic Products for the Treatment of Atopic Dermatitis in Pediatric Patients with Inadequate Response to Topical Prescription Therapy. Dermatologic and Ophthalmic Drugs Advisory Committee Meeting; 2015.
  6. Akpek E K., Dart J. K., Watson St., Christen W., Dursun D., Yoo S., et al. A randomised trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology. 2004; 111 (3); 476.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Eco-Vector


 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).